{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T01:51:26Z","timestamp":1785894686969,"version":"3.56.0"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T00:00:00Z","timestamp":1778889600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005565","name":"Johnson &amp; Johnson Innovative Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005565","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005205","name":"Johnson &amp; Johnson Innovative Medicine","doi-asserted-by":"publisher","award":["67896049PUH4007"],"award-info":[{"award-number":["67896049PUH4007"]}],"id":[{"id":"10.13039\/100005205","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jhltopen.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JHLT Open"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jhlto.2026.100599","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T15:24:01Z","timestamp":1779290641000},"page":"100599","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Absolute versus change in pulmonary vascular resistance in relation to European Society of Cardiology\/European Respiratory Society risk change in pulmonary arterial hypertension"],"prefix":"10.1016","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8019-8699","authenticated-orcid":false,"given":"Stijn C.M.","family":"Donker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.B.","family":"Wild","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel X.","family":"Augustine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay","family":"Suntharalingam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert V. MacKenzie","family":"Ross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arie P.J.","family":"van Dijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph D.","family":"Maxwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Oxborough","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dick H.J.","family":"Thijssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhlto.2026.100599_bib1","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.024969","article-title":"Mortality in pulmonary arterial hypertension in the modern era: early insights from the pulmonary hypertension association registry","volume":"11","author":"Chang","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jhlto.2026.100599_bib2","doi-asserted-by":"crossref","DOI":"10.1177\/2045894020977300","article-title":"Epidemiology of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: identification of the most accurate estimates from a systematic literature review","volume":"11","author":"Leber","year":"2021","journal-title":"Pulm Circ"},{"key":"10.1016\/j.jhlto.2026.100599_bib3","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1093\/eurheartj\/ehac237","article-title":"2022 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"43","author":"Humbert","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jhlto.2026.100599_bib4","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.21037\/cdt-20-348","article-title":"Treatment of right ventricular dysfunction and heart failure in pulmonary arterial hypertension","volume":"10","author":"Inampudi","year":"2020","journal-title":"Cardiovasc Diagn Ther"},{"key":"10.1016\/j.jhlto.2026.100599_bib5","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1183\/09031936.00116313","article-title":"Upfront triple combination therapy in pulmonary arterial hypertension: a pilot study","volume":"43","author":"Sitbon","year":"2014","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jhlto.2026.100599_bib6","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/j.healun.2021.06.020","article-title":"Effect of riociguat on right ventricular function in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension","volume":"40","author":"Benza","year":"2021","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.jhlto.2026.100599_bib7","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/j.amjcard.2019.07.026","article-title":"Echocardiographic assessment of right ventricular function and response to therapy in pulmonary arterial hypertension","volume":"124","author":"Shelburne","year":"2019","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jhlto.2026.100599_bib8","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1164\/ajrccm.165.6.2106079","article-title":"Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: a double-blind, randomized, placebo-controlled trial","volume":"165","author":"Simonneau","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jhlto.2026.100599_bib9","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1056\/NEJMoa020204","article-title":"Inhaled iloprost for severe pulmonary hypertension","volume":"347","author":"Olschewski","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhlto.2026.100599_bib10","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1056\/NEJM199602013340504","article-title":"A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension","volume":"334","author":"Barst","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhlto.2026.100599_bib11","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01323-2024","article-title":"Risk stratification and treatment goals in pulmonary arterial hypertension","volume":"64","author":"Dardi","year":"2024","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jhlto.2026.100599_bib12","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2022-002054","article-title":"Prognostic impact of follow-up pulmonary vascular resistance in pulmonary arterial hypertension","volume":"9","author":"Suzuki","year":"2022","journal-title":"Open Heart"},{"key":"10.1016\/j.jhlto.2026.100599_bib13","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/S0735-1097(02)02012-0","article-title":"Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: prognostic factors and survival","volume":"40","author":"Sitbon","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jhlto.2026.100599_bib14","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1164\/rccm.202004-1006OC","article-title":"Risk reduction and hemodynamics with initial combination therapy in pulmonary arterial hypertension","volume":"203","author":"Badagliacca","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jhlto.2026.100599_bib15","doi-asserted-by":"crossref","first-page":"D22","DOI":"10.1016\/j.jacc.2013.10.027","article-title":"Right heart adaptation to pulmonary arterial hypertension: physiology and pathobiology","volume":"62","author":"Vonk-Noordegraaf","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jhlto.2026.100599_bib16","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1161\/CIRCULATIONAHA.117.029254","article-title":"Prognostic value of follow-up hemodynamic variables after initial management in pulmonary arterial hypertension","volume":"137","author":"Weatherald","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jhlto.2026.100599_bib17","doi-asserted-by":"crossref","first-page":"e73","DOI":"10.1016\/j.healun.2025.04.015","article-title":"International Society for Heart and Lung Transplantation (ISHLT) Consensus Statement on Risk Stratification in Pulmonary Arterial Hypertension","volume":"44","author":"Sahay","year":"2025","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.jhlto.2026.100599_bib18","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1186\/s13643-021-01816-0","article-title":"The prognostic significance of the alterations of pulmonary hemodynamics in patients with pulmonary arterial hypertension: a meta-regression analysis of randomized controlled trials","volume":"10","author":"Sung","year":"2021","journal-title":"Syst Rev"},{"key":"10.1016\/j.jhlto.2026.100599_bib19","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1016\/j.amjcard.2012.06.011","article-title":"Hemodynamics in pulmonary arterial hypertension: current and future perspectives","volume":"110","author":"Saggar","year":"2012","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jhlto.2026.100599_bib20","doi-asserted-by":"crossref","first-page":"G11","DOI":"10.1530\/ERP-17-0071","article-title":"Echocardiographic assessment of pulmonary hypertension: a guideline protocol from the British Society of Echocardiography","volume":"5","author":"Augustine","year":"2018","journal-title":"Echo Res Pract"},{"key":"10.1016\/j.jhlto.2026.100599_bib21","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/ERP-19-0050","article-title":"Normal reference intervals for cardiac dimensions and function for use in echocardiographic practice: a guideline from the British Society of Echocardiography","volume":"7","author":"Harkness","year":"2020","journal-title":"Echo Res Pract"},{"key":"10.1016\/j.jhlto.2026.100599_bib22","article-title":"Age, risk and outcomes in idiopathic pulmonary arterial hypertension","volume":"51","author":"Hoeper","year":"2018","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jhlto.2026.100599_bib23","series-title":"An R companion to applied regression","author":"Fox","year":"2019"},{"key":"10.1016\/j.jhlto.2026.100599_bib24","first-page":"7","article-title":"Diagnostic checking in regression relationships","volume":"2","author":"Zeileis","year":"2002","journal-title":"R News"},{"key":"10.1016\/j.jhlto.2026.100599_bib25","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/1471-2105-12-77","article-title":"pROC: an open-source package for R and S+ to analyze and compare ROC curves","volume":"12","author":"Robin","year":"2011","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.jhlto.2026.100599_bib26","unstructured":"Zhang D. Rsq: R-squared and related measures. R package version 2.7: 2024. Available from: \u3008https:\/\/CRAN.R-project.org\/package=rsq\u3009. Accessed March 13, 2026."},{"key":"10.1016\/j.jhlto.2026.100599_bib27","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00225-2024","article-title":"Prognostic role of haemodynamics at follow-up in patients with pulmonary arterial hypertension: a challenge to current European Society of Cardiology\/European Respiratory Society risk tools","volume":"10","author":"Dardi","year":"2024","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.jhlto.2026.100599_bib28","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.01353-2024","article-title":"Influence of age in the assessment of therapeutic response in patients with pulmonary arterial hypertension","volume":"11","author":"Dardi","year":"2025","journal-title":"ERJ Open Res"}],"container-title":["JHLT Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950133426001205?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950133426001205?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T01:23:08Z","timestamp":1785892988000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2950133426001205"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":28,"alternative-id":["S2950133426001205"],"URL":"https:\/\/doi.org\/10.1016\/j.jhlto.2026.100599","relation":{},"ISSN":["2950-1334"],"issn-type":[{"value":"2950-1334","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Absolute versus change in pulmonary vascular resistance in relation to European Society of Cardiology\/European Respiratory Society risk change in pulmonary arterial hypertension","name":"articletitle","label":"Article Title"},{"value":"JHLT Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhlto.2026.100599","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of International Society for Heart and Lung Transplantation.","name":"copyright","label":"Copyright"}],"article-number":"100599"}}